Deciem Scales Premium Skincare With NIOD Expansion Into Sephora Stores
Beauty Independent reports that Deciem is positioning its high-end NIOD brand as the next major growth engine following the massive success of The Ordinary. After launching in 200 Sephora locations across North America this August, the science-focused label saw sales jump more than 200% in the first three weeks of September. The company now expects the brand to triple or even quintuple its current scale within three years.

Context from Industry Pulse
Deciem’s push into premium science-driven skincare aligns with a broader industry shift toward high-efficacy ingredients like copper peptides. While recent market coverage has highlighted the potential of specialized categories like SPF patches, tween-focused cosmetics, and even experimental dry conditioning for hair, the NIOD expansion tests whether price-sensitive shoppers will trade up for technical sophistication. Executives are increasingly focused on bridging the gap between clinical innovation and the user experience, moving beyond the simple ingredient-led marketing that first propelled The Ordinary to billion-dollar heights. Success here would prove that Deciem can sustain a multi-brand portfolio that spans both mass-market and luxury price points.
The Industry Pulse Bottom Line
The Sephora expansion demonstrates that Deciem is no longer just a one-hit wonder with The Ordinary. If the company can convince 'skintellectuals' to pay triple for technical refinements and better packaging, it will secure a high-margin future in the prestige tier.